Post by Joanna Sadowska, PhD, EMBA

3 Big Pharma & Biotech News You Need to Know Watch to See What Happened Last Week 1. Vertex Pharmaceuticals signs $10B deal ⁠with Crinetics Pharmaceuticals ⁠ on hormonal rare disease - Vertex is expanding its portfolio beyond CF with programs in kidney disease, Type 1 diabetes, pain management, and now hormonal rare disease 2. Novartis acquires UK-based Myricx Bio for up to $1.5 billion - the acquisition brings new ADCs targeting B7H3 and HER2. The assets are still in preclinical development. 3. AstraZeneca signs $2.1B deal with Sino Biopharmaceutical Limited for chronic obstructive pulmonary disease assets - The asset has already entered Phase 3 and could potentially challenge Merck's Ohtuvayre. What would you add to the list? Drop your thoughts in the comments. ---------- Hi! I am Joanna, and my friends call me Dr Jojo 🌸 𝐈 𝐡𝐞𝐥𝐩 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬 𝐚𝐧𝐝 𝐞𝐧𝐭𝐫𝐞𝐩𝐫𝐞𝐧𝐞𝐮𝐫𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐡𝐞𝐢𝐫 𝐯𝐚𝐥𝐮𝐞 𝐚𝐧𝐝 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 🔔 Follow for insights ♻️ Share if you find it interesting 📩 Book a consultation to grow your business and generate leads

Video Content